相关实验视频

Updated: Jul 9, 2025

Protection of H9c2 Myocardial Cells from Oxidative Stress by Crocetin via PINK1/Parkin Pathway-Mediated Mitophagy

Protection of H9c2 Myocardial Cells from Oxidative Stress by Crocetin via PINK1/Parkin Pathway-Mediated Mitophagy

Published on: May 26, 2023

提升PTPN1的调节会通过抑制线粒细胞吸收来加剧内毒性诱导的心脏功能障碍

Qixiang Song¹, Heng Ma¹, Lili Zhu¹

¹Department of Pathophysiology, School of Basic Medical Science, Central South University, 110 Xiangya Road, Changsha 410083, China; Key Laboratory of Sepsis Translational Medicine of Hunan, Central South University, 110 Xiangya Road, Changsha 410083, China.

International immunopharmacology

|December 3, 2023

概括

蛋白氨酸酸酶非受体1型 (PTPN1) 通过阻断线粒细胞衰变,恶化败血症引起的心脏功能障碍. 抑制PTPN1可以通过恢复髓和心脏功能来治疗内毒性.

科学领域:

心血管生物学心血管生物学
线粒体生物学线粒体生物学
败血症病理生理学病理生理学

背景情况:

败血症会导致心脏功能障碍和线粒体损伤.
线粒体,受损线粒体的选择性降解,起着保护作用.
蛋白氨酸酸酶非受体1型 (PTPN1) 在败血症诱导的线粒的作用尚不清楚.

研究的目的:

为了研究PTPN1在败血症期间的线粒细胞衰变中的作用.
阐明PTPN1对线粒的作用背后的机制.
评估PTPN1抑制剂作为内毒素引起的心脏功能障碍的治疗方法.

主要方法:

在小鼠中由脂聚糖 (LPS) 诱导的内毒性模型.
评估PTPN1抑制剂克拉拉胺 (CLA) 的疗效.
评估线粒体功能,线粒体标记物和蛋白质表达.
在体外研究中使用H9c2心肌细胞和STAT3通路分析.

主要成果:

在内毒性小鼠中,CLA治疗改善了心脏功能和线粒体健康.
PTPN1的上调会损害线粒体和恶化心肌细胞中的线粒体损伤.
PTPN1与STAT3相互作用,减少其酸化并抑制PINK1/PRKN转录.
通过促进体结合,STAT3直接调节PINK1和PRKN转录.

结论:

通过抑制线粒细胞衰变,PTPN1在内毒性病中加剧心脏功能障碍.
这种抑制通过STAT3脱化和减少PINK1/PRKN转录发生.
向PTPN1为败血症引起的心脏功能障碍提供了潜在的治疗策略.

关键词:

心脏功能障碍是什么心脏功能障碍末端毒性病 (Endotoxemia) 是一种导致内毒性病的疾病.线粒细胞衰变 - - 线粒细胞衰变 (mitophagy) 是一种一个PTPN1一个PTPN1 在STAT3中,我们可以使用STAT3.

更多相关视频

Cecal Ligation and Puncture-induced Sepsis as a Model To Study Autophagy in Mice

Cecal Ligation and Puncture-induced Sepsis as a Model To Study Autophagy in Mice

Published on: February 9, 2014

Time-Lapse Video Microscopy for Assessment of EYFP-Parkin Aggregation as a Marker for Cellular Mitophagy

Time-Lapse Video Microscopy for Assessment of EYFP-Parkin Aggregation as a Marker for Cellular Mitophagy

Published on: May 4, 2016

相关概念视频

Regulation of the Unfolded Protein Response

Regulation of the Unfolded Protein Response

Inositol-requiring kinase one or IRE1 is the most conserved eukaryotic unfolded protein response (UPR) receptor. It is a type I transmembrane protein kinase receptor with a distinctive site-specific RNase activity. As the binding mechanics of the misfolded proteins with the N-terminal domain of IRE-1 are unclear, three binding models — direct, indirect, and allosteric -- are proposed for receptor activation. Nevertheless, it is known that once a misfolded protein associates with IRE1, it...

The Unfolded Protein Response

The Unfolded Protein Response

The ER is the hub of protein synthesis in a cell. It has robust systems to quality control protein folding and also for degradation of terminally misfolded proteins. Under normal conditions, a small proportion of misfolded proteins that cannot be salvaged need to be transported to the cytoplasm by the ER-associated degradation or ERAD pathways. However, if the ERAD cannot handle the misfolded proteins, the cell activates the unfolded protein response or UPR to adjust the protein folding...

Pathophysiology of Heart Failure

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...